#Japan #Tokyo #Exosomes #AiREV® #BBTF

BBTF Presents AiREV® at ASGH 2025

BBTF, a pioneering biotechnology company, recently marked a significant presence at the 5th Asia Summit on Global Health (ASGH) held at the Hong Kong Convention and Exhibition Centre on May 25-26, 2025. This event, co-hosted by the Hong Kong Special Administrative Region Government and the Hong Kong Trade Development Council, stands as a forefront healthcare event focusing on global health initiatives in Asia.

The theme of the 2025 summit was “Fostering Global Collaboration for a Shared Future.” It attracted over 2,800 participants from more than 40 countries and regions, featuring renowned speakers across international healthcare sectors. Among the attendees, BBTF was the only representative from Japan, thereby capturing significant attention from various global delegates as well as local Japanese participants.

During the summit, BBTF showcased its flagship product, AiREV®, a fermented equine milk exosome. The company presented new efficacy studies demonstrating its effectiveness in areas such as anti-inflammatory properties, moisture retention, barrier function enhancement, and wound healing.

Understanding The Fermented Equine Milk Exosome AiREV®

AiREV® operates on the premise of utilizing fermented exosomes derived from equine milk, which have been subjected to rigorous scientific evaluation. Patented under number 7162693, AiREV® has demonstrated the ability to inhibit the production of TARC/CCL17, a chemokine associated with various allergic conditions such as atopic dermatitis, contact dermatitis, and other allergy-related ailments.

Exosomes, which range from 50 nm to 150 nm in diameter, are membrane vesicles secreted by nearly all cell types and play a critical role in cellular communication within the body. They carry various proteins, lipids, and RNAs that facilitate functional and physiological changes in recipient cells. Their potential applications span across areas, including immune response mediation against pathogens and tumors, tissue repair, and neurological communication.

Future Developments in Japan

The participation at ASGH has generated significant interest from international attendees towards the efficacy of AiREV®. Following this exposure, BBTF is set to collaborate at the Exosome Medical Promotion Initiative's conference scheduled for June 22, 2025, at the University of Tokyo. Esteemed speakers, including Professor Takahiro Ootani and Professor Ryo Konno, will discuss advancements in exosome-based therapies, with AiREV® being a focal topic.

Event Details

• - Date: June 22, 2025
• - Time: 14:00 – 16:00
• - Venue: University of Tokyo, Yamagami Hall (Hongo campus)
• - Speakers:

- Professor Takahiro Ootani (Tokyo Medical University) discussing market trends in exosome therapeutics.
- Professor Ryo Konno (Jichi Medical University) addressing topics related to endometriosis and the application of AiREV® in enhancing immune recovery.

This collaboration highlights BBTF’s commitment to improving well-being through innovative biotechnological solutions while increasing public awareness of the potential applications of exosomes in healthcare.

About BBTF and Its Subsidiaries

BBTF specializes in the marketing and promotion of regenerative medical products both domestically and internationally, as well as supplying cosmetic raw materials and developing original cosmetic brands. Through a wide range of endeavors in regenerative medicine and beauty, BBTF is dedicated to delivering high-quality, reliable products that meet diverse consumer needs.

Moreover, BBF has structured a value chain focused on exosome research and development, establishing technologies in cell culture and supporting regenerative medicine institutions globally. BBTF continuously seeks to make regenerative medicine more accessible and approachable in everyday life.

For more information or inquiries regarding BBTF and its endeavors, contact us at:

• - Phone: 03-6665-0802
• - Email: info@bbtf.co.jp
• - Website: BBTF Official Site